GGrantIndex
Sort

11,323 grants matching glioblastoma

In vivo Drug Testing of Pediatric CNS Tumors Using Patient Derived Orthotopic Xenograft Models

$237,825
Xiaonan Li · Lurie Children'S Hospital Of Chicago · U01 · FY2025 · CA

Investigating ASPM regulation of asymmetric division for therapeutic opportunities

$237,750
Claudia Katharina Petritsch · University Of California, San Francisco · R21 · FY2017 · NS

Functional long noncoding RNAs in human glioma

$237,750
Daniel A Lim · University Of California, San Francisco · R21 · FY2017 · NS

Antigens for Molecularly Targeted Vaccines for Progressive Glioma

$237,750
Hideho Okada · University Of California, San Francisco · R21 · FY2016 · NS

Role of FAP-positive cells in immune response to irradiated glioblastoma

$237,724
Claire Isabelle Vanpouille-Box · Weill Medical Coll Of Cornell Univ · R21 · FY2023 · CA

Molecular Mechanisms of SPARC Mediated Glioma Invasion

$237,704
Jeremy N Rich · Cleveland Clinic Lerner Com-Cwru · R01 · FY2010 · NS

Regulation of RTKs by the SETA/CIN85 Complex in Glioma

$237,688
University Of Texas Md Anderson Can Ctr · R01 · FY2005 · CA

Dissecting Glioma Genesis through a Glial-Specific Mouse Model

$237,667
Wei Zhang · University Of Tx Md Anderson Can Ctr · R01 · FY2013 · CA

Nervous system control and regulation of the immune system following neurological insults

$237,653
Katayoun Ayasoufi · Duke University · R00 · FY2024 · NS

Molecular Mechanisms of SPARC Mediated Glioma Invasion

$237,492
Jeremy N Rich · Duke University · R01 · FY2007 · NS

GSH TRANSFERASE PI POLYMORPHISM AND DRUG RESISTANCE

$237,367
University Of Texas Md Anderson Can Ctr · R01 · FY2001 · CA

Regulation of Metastasis and Angiogenesis by Autotaxin and its Products

$237,348
Mary Stracke · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA

Irreversible electroporation for combinatorial GBM treatment

$237,254
Rafael Vidal Davalos · Wake Forest University Health Sciences · P01 · FY2018 · CA

Genetic Mouse Models of Glioma

$236,930
Luis F Parada · Sloan-Kettering Inst Can Research · R01 · FY2015 · CA

Photothermal Nanoparticles Immune Engineer Tumor-specific T cells for Adoptive Cell Therapy

$236,915
Rohan Fernandes · Univ Of Maryland, College Park · R01 · FY2025 · CA

Genetically-Modified Neural Stem Cell Based Virotherapy for Invasive Gliomas

$236,853
Atique U. Ahmed · University Of Chicago · R00 · FY2014 · CA

The Proneural Perivascular Niche and Therapeutic Response

$236,782
Eric C Holland · Sloan-Kettering Inst Can Research · U54 · FY2012 · CA

The Proneural Perivascular Niche and Therapeutic Response

$236,656
Eric C Holland · Fred Hutchinson Cancer Research Center · U54 · FY2014 · CA

COMBINATION OF IL13RALPHA2 CAR T-CELL THERAPY WITH PD-1 IMMUNE CHECKPOINT BLOCKADE FOR TREATMENT OF GLIOBLASTOMA

$236,627
Northwestern University · · FY2017 · Department of the Army

Administrative Core

$236,428
Li Ding · Washington University · U2C · FY2019 · CA

Development of A Novel Imaging Strategy for Evaluation of CAR T-Cell Therapy in Glioblastoma

$236,351
Corinne Beinat · Stanford University · R21 · FY2021 · NS

Chronotherapy for glioblastoma

$236,250
Erik Herzog · Washington University · R21 · FY2021 · NS

Experimental Therapeutics for Brain Cancer

$236,210
University Of Minnesota Twin Cities · R01 · FY2005 · CA

Molecular Imaging of Pyruvate Kinase M2

$236,100
Corinne Beinat · Stanford University · R21 · FY2022 · EB

Targeting CD44 signaling in regulating glioblastoma stemness and immune response

$235,979
Bangxing B Hong · Augusta University · R21 · FY2023 · NS